PPBT Stock Latest News
Company AnnouncementsPurple Biotech Reinstates Isaac Israel as Interim CEO in Leadership Reshuffle2w ago6KPPBT
Company AnnouncementsPurple Biotech Shareholders Approve All AGM Proposals, File Results with U.S. SEC1M ago6KPPBT
Market News3 Penny Stocks on Investors’ Radar after Big Moves, 9/03/261M agoBIAFGPRO
Market NewsWhy Is Purple Biotech Stock (PPBT) Up 42% Today?1M agoPPBT
Company AnnouncementsPurple Biotech Gains New U.S. Patent Allowance for CAPTN-3 Cancer Immunotherapy Platform1M ago6KPPBT
Company AnnouncementsPurple Biotech Posts Q2 2026 Results as IM1240 Preclinical Data Strengthen Immunotherapy Platform2M ago6KPPBT
Company AnnouncementsPurple Biotech Sets September 8, 2026 AGM to Reshape Board Roles and Compensation Policy2M ago6KPPBT- Company AnnouncementsPurple Biotech Updates Investors on CAPTN-3 Platform and Pipeline as IM1240 Nears 2027 Clinic Entry4M ago6KPPBT
The FlyPurple Biotech presents new IM1240 data at EACR4M agoPPBT
Company AnnouncementsPurple Biotech Unveils IM1240 Preclinical Data at EACR 2026, Validating CAPTN-3 Immunotherapy Platform4M ago6KPPBT
Company AnnouncementsPurple Biotech Q1 2026 Results Highlight CAPTN-3 Pivot and IM1240 Preclinical Momentum5M ago6KPPBT
Company AnnouncementsPurple Biotech Unveils Promising IM1240 Preclinical Data From CAPTN-3 Immunotherapy Platform6M ago6KPPBT
Company AnnouncementsPurple Biotech Forms Scientific Advisory Board to Drive CAPTN-3 Tri-Specific Antibody Platform6M ago6KPPBT- Company AnnouncementsPurple Biotech Taps Converge Bio’s AI to Turbocharge Tri-Specific Antibody Platform7M ago6KPPBT
